Mixed tocotrienols inhibit prostate carcinogenesis in TRAMP mice

Area of Science:

• Nutrition and Cancer Research
• Molecular Biology
• Animal Models of Disease

Background:

• Tocotrienols, a class of vitamin E, exhibit various biological activities.
• Prostate cancer remains a significant health concern, necessitating novel preventative strategies.
• The TRAMP mouse model is widely used to study prostate tumorigenesis.

Purpose of the Study:

• To investigate the efficacy of a mixed-tocotrienol diet in preventing prostate cancer.
• To evaluate the impact of mixed tocotrienols on tumor development and progression in TRAMP mice.

Main Methods:

• Male TRAMP mice were fed diets containing 0.1%, 0.3%, or 1% mixed tocotrienols.
• Control groups included TRAMP mice on a standard diet and wild-type mice.
• Tumor incidence, weight, neoplastic lesion grading, and protein expression were analyzed.

Main Results:

• Mixed tocotrienol diets significantly reduced prostate tumor incidence and genitourinary tract weight.
• High-grade neoplastic lesions were decreased in tocotrienol-fed groups.
• Increased expression of proapoptotic proteins (BAD, cleaved caspase-3) and cell cycle inhibitors (p21, p27) was observed.

Conclusions:

• Mixed tocotrienols effectively suppress prostate tumorigenesis in the TRAMP mouse model.
• The anti-tumorigenic effects are mediated by modulating apoptosis and cell cycle regulatory proteins.
• These findings suggest a potential role for tocotrienols in prostate cancer prevention.